CoChat

Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood–Brain Barrier Integrity

Bull, Daniel, Schweitzer, Christophe, Bichsel, Colette, Britschgi, Markus, Gutbier, Simon · 2022 · Cells
Cited by 14

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The blood–brain barrier (BBB) regulates the interaction between the highly vulnerable central nervous system (CNS) and the peripheral parts of the body. Disruption of the BBB has been associated with multiple neurological disorders, in which immune pathways in microglia are suggested to play a key role. Currently, many in vitro BBB model systems lack a physiologically relevant microglia component in order to address questions related to the mechanism of BBB integrity or the transport of molecules between the periphery and the CNS. To bridge this gap, we redefined a serum-free medium in order to allow for the successful co-culturing of human inducible pluripotent stem cell (hiPSC)-derived microglia and hiPSC-derived brain microvascular endothelial-like cells (BMECs) without influencing barrier properties as assessed by electrical resistance. We demonstrate that hiPSC-derived microglia exposed to lipopolysaccharide (LPS) weaken the barrier integrity, which is associated with the secretion of several cytokines relevant in neuroinflammation. Consequently, here we provide a simplistic humanised BBB model of neuroinflammation that can be further extended (e.g., by addition of other cell types in a more complex 3D architecture) and applied for mechanistic studies and therapeutic compound profiling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11030419

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 35

  1. Hawkins, 2005, The blood-brain barrier/neurovascular unit in health and disease, Pharmacol. Rev., 57, 173, 10.1124/pr.57.2.4 · DOI · Paper page
  2. Iadecola, 2017, The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease, Neuron, 96, 17, 10.1016/j.neuron.2017.07.030 · DOI · Paper page
  3. Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 · DOI · Paper page
  4. Zlokovic, 2008, The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 · DOI · Paper page
  5. Heneka, 2015, Neuroinflammation in Alzheimer’s disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
  6. Xiao, 2020, Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders, Front. Neurosci., 14, 764, 10.3389/fnins.2020.00764 · DOI
  7. Beach, 1989, Patterns of gliosis in alzheimer’s disease and aging cerebrum, Glia, 2, 420, 10.1002/glia.440020605 · DOI · Paper page
  8. Fahn, 2018, The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future, Parkinsonism Relat. Disord., 46, S1, 10.1016/j.parkreldis.2017.07.020 · DOI
  9. Gogoleva, 2019, The Role of Microglia in the Homeostasis of the Central Nervous System and Neuroinflammation, Mol. Biol., 53, 696, 10.1134/S0026893319050054 · DOI
  10. Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease, Nat. Genet., 45, 1452, 10.1038/ng.2802 · DOI · Paper page
  11. Kunkle, 2019, Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing, Nat. Genet., 51, 414, 10.1038/s41588-019-0358-2 · DOI · Paper page
  12. Gastfriend, 2018, Modeling the blood-brain barrier: Beyond the endothelial cells, Curr. Opin. Biomed. Eng., 5, 6, 10.1016/j.cobme.2017.11.002 · DOI · Paper page
  13. Speicher, 2019, Generating microglia from human pluripotent stem cells: Novel in vitro models for the study of neurodegeneration, Mol. Neurodegener., 14, 46, 10.1186/s13024-019-0347-z · DOI · Paper page
  14. Reich, 2021, Alzheimer’s Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia, Front. Immunol., 11, 3918, 10.3389/fimmu.2020.617860 · DOI · Paper page
  15. Chen, 2021, Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors, Stem Cell Rep., 16, 1363, 10.1016/j.stemcr.2021.03.010 · DOI · Paper page
  16. Workman, 2020, Recent advances in human iPSC-derived models of the blood-brain barrier, Fluids Barriers CNS, 17, 30, 10.1186/s12987-020-00191-7 · DOI
  17. Prashanth, A., Donaghy, H., Stoner, S.P., Hudson, A.L., Wheeler, H.R., Diakos, C.I., Howell, V.M., Grau, G.E., and McKelvey, K.J. (2021). Are in vitro human blood–brain–tumor-barriers suitable replacements for in vivo models of brain permeability for novel therapeutics?. Cancers, 13. · DOI
  18. Park, 2019, Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies, Nat. Commun., 10, 2621, 10.1038/s41467-019-10588-0 · DOI · Paper page
  19. Morrison, 2015, StemBANCC: Governing Access to Material and Data in a Large Stem Cell Research Consortium, Stem Cell Rev., 11, 681, 10.1007/s12015-015-9599-3 · DOI · Paper page
  20. Gutbier, S., Wanke, F., Dahm, N., Rn, A., Zimmermann, S., Christensen, K., Köchl, F., Rautanen, A., Hatje, K., and Geering, B. (2020). Large-Scale Production of Human iPSC-Deriveümmelid Macrophages for Drug Screening. Int. J. Mol. Sci., 21. · DOI · Paper page
  21. Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467 · DOI · Paper page
  22. Simonneau, 2021, Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays, Fluids Barriers CNS, 18, 43, 10.1186/s12987-021-00276-x · DOI
  23. Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M.C., and ten Dijke, P. (2017). TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int. J. Mol. Sci., 18. · DOI · Paper page
  24. Ma, 2020, TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering, Front. Cell Dev. Biol., 8, 260, 10.3389/fcell.2020.00260 · DOI · Paper page
  25. Ferrari, 2009, Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis, J. Cell. Physiol., 219, 449, 10.1002/jcp.21706 · DOI · Paper page
  26. Nguyen, 2018, TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis, Mucosal Immunol., 11, 415, 10.1038/mi.2017.72 · DOI
  27. Evrard, 2016, Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability, Nat. Commun., 7, 11853, 10.1038/ncomms11853 · DOI · Paper page
  28. Spittau, 2020, The Role of TGFβ Signaling in Microglia Maturation and Activation, Trends Immunol., 41, 836, 10.1016/j.it.2020.07.003 · DOI · Paper page
  29. Yao, 2013, Monocyte chemoattractant protein-1 and the blood–brain barrier, Cell. Mol. Life Sci., 71, 683, 10.1007/s00018-013-1459-1 · DOI · Paper page
  30. Chai, 2015, Expression of Neuronal CXCL10 Induced by Rabies Virus Infection Initiates Infiltration of Inflammatory Cells, Production of Chemokines and Cytokines, and Enhancement of Blood-Brain Barrier Permeability, J. Virol., 89, 870, 10.1128/JVI.02154-14 · DOI
  31. Maysami, 2015, Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke, J. Neuroinflamm., 12, 140, 10.1186/s12974-015-0359-8 · DOI
  32. Ubogu, 2006, Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation, J. Neuroimmunol., 179, 132, 10.1016/j.jneuroim.2006.06.004 · DOI
  33. Lu, 2021, Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate, Proc. Natl. Acad. Sci. USA, 118, e2016950118, 10.1073/pnas.2016950118 · DOI · Paper page
  34. Lippmann, 2020, Commentary on human pluripotent stem cell-based blood–brain barrier models, Fluids Barriers CNS, 17, 64, 10.1186/s12987-020-00222-3 · DOI
  35. Han, 2021, Roles of Macrophages in the Development and Treatment of Gut Inflammation, Front. Cell Dev. Biol., 9, 385, 10.3389/fcell.2021.625423 · DOI · Paper page

Cited by

See all 14

Metadata

Authors
Bull, D., Schweitzer, C., Bichsel, C., Britschgi, M., & Gutbier, S.
Affiliations
  • ARUK UCL Drug Discovery Institute, University College London, London WC1E 6BT, UK
  • Roche Pharma Research and Early Development, Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland
  • Roche Pharma Research and Early Development, Pharmaceutical Sciences and The Roche Institute for Translational Bioengineering, Roche Innovation Center Basel, 4070 Basel, Switzerland
  • Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Venue
Cells
Publisher
MDPI AG
Published
2022-01-26
Volume
11
Issue
3
Pages
419
ISSN
2073-4409
Cited by
14
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood–Brain Barrier Integrity. https://app.cochat.ai/papers/10.3390/cells11030419
The paper
Bull, D., Schweitzer, C., Bichsel, C., Britschgi, M., & Gutbier, S. (2022). Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood–Brain Barrier Integrity. Cells. https://doi.org/10.3390/cells11030419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.